INOV vs. QXO, YY, ADEX, LTRPA, LIFW, LYT, NHIQ, NH, WEJOF, and NTNX
Should you be buying Inovalon stock or one of its competitors? The main competitors of Inovalon include QXO (QXO), JOYY (YY), Adit EdTech Acquisition (ADEX), Liberty TripAdvisor (LTRPA), MSP Recovery (LIFW), Lytus Technologies Holdings PTV. (LYT), NantHealth (NHIQ), NantHealth (NH), Wejo Group (WEJOF), and Nutanix (NTNX).
Inovalon vs. Its Competitors
QXO (NASDAQ:QXO) and Inovalon (NASDAQ:INOV) are both data processing & preparation industry companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership, media sentiment and dividends.
QXO presently has a consensus price target of $33.20, suggesting a potential upside of 53.51%. Given QXO's stronger consensus rating and higher possible upside, analysts clearly believe QXO is more favorable than Inovalon.
QXO has a beta of 2.41, indicating that its share price is 141% more volatile than the S&P 500. Comparatively, Inovalon has a beta of 0.53, indicating that its share price is 47% less volatile than the S&P 500.
QXO has a net margin of 30.08% compared to Inovalon's net margin of 6.73%. Inovalon's return on equity of 10.97% beat QXO's return on equity.
In the previous week, QXO had 8 more articles in the media than Inovalon. MarketBeat recorded 8 mentions for QXO and 0 mentions for Inovalon. QXO's average media sentiment score of 0.78 beat Inovalon's score of 0.00 indicating that QXO is being referred to more favorably in the media.
Inovalon has higher revenue and earnings than QXO. QXO is trading at a lower price-to-earnings ratio than Inovalon, indicating that it is currently the more affordable of the two stocks.
58.7% of QXO shares are held by institutional investors. Comparatively, 33.2% of Inovalon shares are held by institutional investors. 51.3% of QXO shares are held by company insiders. Comparatively, 49.8% of Inovalon shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Summary
QXO beats Inovalon on 11 of the 17 factors compared between the two stocks.
Get Inovalon News Delivered to You Automatically
Sign up to receive the latest news and ratings for INOV and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding INOV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Inovalon Competitors List
Related Companies and Tools
This page (NASDAQ:INOV) was last updated on 7/18/2025 by MarketBeat.com Staff
